EG · a US exchange · USD · Market cap $14.1B · 3,064 employees
Everest Group, Ltd., together with subsidiaries, provides reinsurance and insurance products in the United States, Europe, and internationally.
FAIL · Does not pass the screen
367.87 USD
At the last full screen 2026-09-09
Screened 2026-09-09 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its accumulation label.
Everest Group holds its Accumulation at $367.87. The statistical read favours the buyers, held for 1 days.
As held on the ledger · 2026-09-09
Phase
Accumulation
Quantitative state
The statistical read favours the buyers, held for 1 days
Price at the screen
$367.87
Valuation
7.77 trailing · 6.16 forward price to earnings
Values screen
FAIL· score 10.0
Beta
0.28
The Workings
Five Screens, Shown in Full
Does not pass. Business activity screen
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Business activity: Financials sector
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads AVOID: it trades at roughly a 31% discount to our $480.00 fair value, moderate competitive moat.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 30.5% margin of safety to the base estimate.
Third-party analyst targets: 15 covering, consensus None. The average target sits +9% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Reinsurer valuation hides a clear ethical fail
Picture a Bermuda reinsurer taking premiums on everything from Florida hurricanes to European factories. Everest Group trades at 6.3 times forward earnings with a 14 percent return on equity, yet the numbers sit beside falling revenue and only moderate competitive protection.
We pass for one straightforward reason. The business activity screen flags the company, and that single ethical breach overrides any apparent cheapness on paper.
The low multiple may simply reflect peak cycle earnings rather than a durable bargain, while consensus targets sit only modestly above the current price. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to Bermuda and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
EG trades on a US exchange (the company is based in Bermuda). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (15 analysts) rates it buy, with a mean price target of $408.
2026-07-27Accumulation$382.57+14.4%Entry 4
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 14.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (15 analysts) rates it buy, with a mean price target of $388.
2026-07-18Accumulation$334.41+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (15 analysts) rates it buy, with a mean price target of $388.
2026-07-03Accumulation$334.41+0.0%Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Accumulation$334.41Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
